绘制癌症表面蛋白质组的地图,以寻找用于免疫治疗的向抗原
Francesco Di Meo1, Brandon Kale1, John M Koomen2
1Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
概括
基于免疫的癌症疗法看起来很有前途,但由于缺乏合适的细胞表面点而受到限制. 最近的技术进步使全面的蛋白质组分析能够发现更广泛的癌症治疗的新点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 基于免疫的疗法,包括抗体治疗和工程T细胞,已被FDA批准用于某些癌症.
- 这些疗法向细胞表面蛋白质 (例如PD-1,CD19),以增强抗瘤反应或重定向T细胞特异性.
- 一个关键的限制是,在所有癌症类型中,适合细胞表面向抗原的稀缺性.
研究的目的:
- 审查最近在识别免疫治疗新型癌症细胞表面点方面的进展.
- 突出全面癌细胞表面蛋白质组分析的潜力.
主要方法:
- 利用质谱学的技术进步,用于细胞表面蛋白质的隔离.
- 使用先进的丰富协议和计算工具进行蛋白质组注释.
- 对癌细胞表面蛋白质组的全面分析.
主要成果:
- 新兴技术有助于对癌细胞表面蛋白质进行详细分析.
- 这可以识别潜在的新型免疫治疗点.
- 该领域的进展正在迅速扩大潜在目标的范围.
结论:
- 发现理想的细胞表面抗原 (在癌症上高度表达,在健康组织中缺席) 对于更广泛的免疫疗法应用至关重要.
- 蛋白质组分析的技术进步是克服当前局限性的关键.
- 这一领域对于开发新的癌症治疗方法具有重大前景.
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


